Article
Survival and prognostic factors in non-small cell lung cancer patients with brain metastases limited access to systemic therapy
2022-12-20
Abstract excerpt
<h4>Background: </h4> Survival after diagnosis of brain metastases in non-small cell lung cancer (NSCLC) patients was dismal even after local therapy (surgery or brain irradiation), partly because of the systemic burden. Paucities of medical oncologists and molecular testing plus disparities in health care coverage resulted in limited access to systemic chemotherapy, let alone targeted drug or immunotherapy, for b...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f3c590b6-985b-5d5e-8b0f-2c585f887485
- DOI
- 10.21203/rs.3.rs-2324452/v1
